Physician profile
Ashley Roth
NPI 1801203179
$261,264.16
in general payments reported to CMS, 2019-2025
20 companies · $127K in 2025
The $127K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $343 · 2021: $421 · 2022: $20K · 2023: $47K · 2024: $66K · 2025: $127K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $158K · Travel and Lodging: $50K · Consulting Fee: $18K · Food and Beverage: $15K · Entertainment: $51.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $157,650.00 |
| Travel and Lodging | $50,031.83 |
| Consulting Fee | $17,575.00 |
| Food and Beverage | $15,125.86 |
| Entertainment | $51.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $257,708.10 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $921.89 | 2020-2025 | Tryptyr, Dailies, Precision7 |
| Johnson & Johnson Surgical Vision, INC. | $623.64 | 2022 | |
| Biotissue Holdings INC. | $584.57 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $360.14 | 2024-2025 | Xdemvy |
| Optos, INC. | $224.62 | 2021-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Intuitive Surgical, INC. | $144.70 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.51 | 2019-2020 | |
| Coopervision INC. | $125.32 | 2019-2023 | Myday Contact Lens |
| Carl Zeiss Meditec Cataract Technology INC. | $103.03 | 2019 | |
| Abbvie INC. | $50.00 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Visionix USA, INC | $46.88 | 2022 | |
| Shire North American Group INC | $37.55 | 2019 | |
| Dompe US, INC. | $30.86 | 2024 | Oxervate |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $27.69 | 2024 | Iyuzeh |
| Topcon Healthcare, INC. | $23.94 | 2023 | |
| Novartis Pharmaceuticals Corporation | $21.18 | 2020 | |
| Bausch & Lomb Americas INC. | $20.21 | 2024 | Miebo |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.